Forgot password?
Sign up today and your first download is free.

Rx Drugs

March 05, 2002 | Daily News

A key Senate Democrat is rejecting AARP's proposal to use the Medicare Trust Fund to finance a comprehensive prescription drug benefit. The lawmaker's statements will likely end speculation on whether the trust funds will be touched to craft a drug benefit, since GOP House leaders also oppose the funding plan.

March 04, 2002 | Daily News

With the pharmaceutical industry already promising a fight, Sen. Byron Dorgan (D-ND), chair of a Senate Commerce and Transportation subcommittee, is planning to introduce a bill that would allow pharmacists and wholesalers to reimport drugs from Canada. The bill is likely to reignite controversy over reimportation, as the Pharmaceutical Research and Manufacturers of America (PhRMA) has promised to fight the impending bill, and an FDA source says the agency has safety concerns regarding the approach.

March 04, 2002 | Daily News

The state of Maine has won round one against a pharmaceutical industry bid to quash the state's prescription drug discount program for low-income residents.

In a Feb. 25 decision, the U.S. District Court for the District of Columbia has ruled in favor of the Healthy Maine Prescription Program (HMP), authorized by HHS to reduce prescription drug costs for needy residents ineligible for Medicaid.

March 04, 2002 | Daily News

Montana is taking several drug manufacturers to court over what the state believes is an abuse of the average wholesale price (AWP) system that it claims has cost Montana millions of dollars.

March 01, 2002 | Daily News

Top House lawmakers are reconsidering their stance on Medicare reform funding and may call for more resources to pay for prescription drug coverage, Medicare+Choice improvements, and provider payment adjustments, according to sources.

March 01, 2002 | Daily News

Pharmacy groups are "very likely" to resume their legal challenge over President Bush's prescription drug discount card following today's (March 1) release of the administration's revised initiative, according to an industry source.

Members of the two key pharmacy groups that successfully halted the administration's original card plan are meeting today to discuss continuing their court action. A source with one of the groups says the revised card plan is almost identical to the first proposal and therefore, violates the federal court injunction.

February 25, 2002 | Daily News

In an unprecedented move, AARP will soon ask Congress to dip into the Medicare Trust Fund to finance a $700 billion Medicare reform bill that would mostly pay for a comprehensive prescription drug benefit, according to an AARP source.

AARP is preparing a letter to both the House and Senate budget committees that will propose taking $350 billion from general revenue and $350 billion from the Medicare Trust Fund, according to the source. The letters will likely be sent this week.

February 20, 2002 | Daily News

A key Senate player in the Medicare prescription drug debate is pursuing increased usage of generic drugs to help cut the cost of a comprehensive drug benefit. Sen. John Rockefeller (D-WV) is examining the potential savings through generics in a bid to save money and increase the chances of enacting a drug benefit this year.

February 20, 2002 | Daily News

Legislation that would deal with all aspects of Medicare reform, including a prescription drug benefit as well as numerous other Medicare reform language, has a "good chance" of passing by "early summer," according to a GOP source.

February 19, 2002 | Daily News

A powerful Senate Democrat last week accused the Bush administration of "cooking the books" on its new Medicare funding request, criticizing Bush's proposed budget for lacking enough money for a prescription drug benefit and provider payment adjustments.

February 15, 2002 | Daily News

A yet-to-be-released congressional document estimates that the provider payment recommendations recently issued by the Medicare Payment Advisory Commission (MedPAC) would cost $174 billion over 10 years. This high price tag is significant because it will force Congress and the administration to pick and choose which MedPAC recommendations to implement in 2002.

February 14, 2002 | Daily News

The recently announced breakup of Merck-Medco has caught the attention of top policymakers on Capitol Hill, who say the failed marriage of the pharmaceutical giant and the pharmacy benefit manager (PBM) could be a significant blow to the House's attempt to pass a prescription drug bill this year. Merck-Medco's endorsement of the House drug bill in the 106th Congress was crucial to the measure's success in the chamber, sources note.

February 13, 2002 | Daily News

Two senators have changed their minds and now will not send letters chastising the head of a major pharmaceutical trade group who speculated the senators were close to endorsing the tripartisan Medicare reform plan.

Last month, Pharmaceutical and Research Manufacturers of America President Alan Holmer told reporters that Sens. Robert Torricelli (D-NJ) and Blanche Lincoln (D-AR) were possibly set to endorse the tripartisan Medicare reform plan that is favored by the White House (Inside CMS, Jan. 31, p1).

February 13, 2002 | Daily News

Building momentum for a significant role for generic drugs in this year's prescription drug debate, a top White House policy advisor said Feb. 13 that generics drugs are a good substitute for costly pharmaceuticals.

After delivering a speech to AARP's board of directors, White House health care advisor Mark McClellan suggested that policymakers should discuss the use of generic drugs as they attempt to craft a comprehensive drug benefit bill. "Frankly," McClellan told Inside CMS, "generics are a good substitute for costly drugs."

February 12, 2002 | Daily News

In what could signal a significant policy shift, a key Senate Democrat said today that a prescription drug benefit should be packaged with other Medicare reforms that would help finance comprehensive drug coverage. The lawmaker also indicated his opposition to "sunsetting" a prescription drug benefit, an idea floated last year by Sen. Edward Kennedy (D-MA).

February 11, 2002 | Daily News

President Bush Feb. 11 touted the tripartisan Medicare reform plan that is expected to be formally introduced in the Senate later this month. While not formally endorsing the tripartisan proposal, Bush's statements are significant because they insinuate the White House clearly favors the plan that has attracted the support of Sens. John Breaux (D-LA), James Jeffords (I-VT), and Chuck Grassley (R-IA).

February 07, 2002 | Daily News

The Democratic-controlled Senate may seek to trump House Speaker Dennis Hastert's (R-IL) recent call for a $300 billion Medicare reform bill by calling for more funds to be devoted to a prescription drug benefit, according to congressional sources.

February 06, 2002 | Daily News

Lawmakers of both parties and beneficiary groups are reacting with skepticism to the administration's proposal to reform Medicare and craft a comprehensive prescription drug program with a net of $190 billion. Congress is expected to significantly increase this figure as lawmakers are calling for at least $300 billion for a drug benefit.

The administration has floated its $190 billion proposal recently and has laid out its plans for Medicare reform, a discount card and prescription drug coverage in a Jan. 28 White House fact sheet.

February 06, 2002 | Daily News

AARP, which has been criticized in the past for not taking a firm stance on various prescription drug bills, is vowing to be more vocal this year and might endorse specific bills.

February 06, 2002 | Daily News



A new bipartisan prescription drug bill has been introduced in the House but Republicans and conservative Democrats are not embracing the measure.